Therefore, the multitude of protective activities of LL‐37 in the colon, and probably other organs, defines this antimicrobial and immune‐regulatory host peptide as a promising therapeutic agent of colon diseases [57]. The gene discussed is CAMP; the disease is colonic disorder.